SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-20-002131
Filing Date
2020-08-14
Accepted
2020-08-14 12:32:25
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clcs_10q.htm 10-Q 468567
2 FORM OF SECURITIES PURCHASE AGREEMENT clcs_ex1051.htm EX-10.51 175887
3 FORM OF 10% OID CONVERTIBLE PROMISSORY NOTE clcs_ex1052.htm EX-10.52 107731
4 FORM OF WARRANT ISSUED TO PURCHASER OF 10% OID CONVERTIBLE PROMISSORY NOTE clcs_ex1053.htm EX-10.53 73320
5 EX-31 clcs_ex31.htm EX-31 9404
6 EX-32 clcs_ex32.htm EX-32 2520
  Complete submission text file 0001640334-20-002131.txt   2983731

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clcs-20200630.xml EX-101.INS 407335
8 XBRL TAXONOMY EXTENSION SCHEMA clcs-20200630.xsd EX-101.SCH 45338
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20200630_lab.xml EX-101.LAB 237476
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20200630_cal.xml EX-101.CAL 25156
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20200630_pre.xml EX-101.PRE 207769
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20200630_def.xml EX-101.DEF 145246
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 201103359
SIC: 2834 Pharmaceutical Preparations